Title of article
Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET)
Author/Authors
Christoph Kaiser، نويسنده , , Hans Peter Brunner-La Rocca، نويسنده , , Peter T Buser، نويسنده , , Piero O. Bonetti، نويسنده , , Stefan Osswald، نويسنده , , Andre Linka، نويسنده , , Alain Bernheim، نويسنده , , Andreas Zutter، نويسنده , , Michael Zellweger، نويسنده , , Leticia Grize، نويسنده , , Matthias E. Pfisterer، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2006
Pages
9
From page
921
To page
929
Abstract
Background
No prospective trial-based data are available for incremental cost-effectiveness of drug-eluting stents (DES) compared with bare-metal stents (BMS) in unselected patients, as treated in everyday practice.
Methods
The Basel stent cost-effective
Journal title
The Lancet
Serial Year
2006
Journal title
The Lancet
Record number
588646
Link To Document